4.7 Article

Tilapia head glycolipids protect mice against dextran sulfate sodium-induced colitis by ameliorating the gut barrier and suppressing NF-kappa B signaling pathway

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 96, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.intimp.2021.107802

Keywords

Tilapia head glycolipids; NF-kappa B; Gut barrier; IBD; Mice

Funding

  1. National Key R&D Programs of China [2018YFD0901103]
  2. Program of Hainan Association for Science and Technology Plans to Youth RD Innovation [QCXM202003]
  3. Hainan Provincial Natural Science Foundation of China [2019RC093]
  4. Scientific Research Foundation of Hainan University [kyqd1662]

Ask authors/readers for more resources

The study evaluated the relieving effect of tilapia head glycolipids (TH-GLs) on DSS-induced colitis in mice and explored its potential mechanism. TH-GLs significantly improved colon lesions, increased mucus secretion, extended colon length, and inhibited inflammatory cytokines. These findings suggest that TH-GLs could potentially be used in treating colitis by improving gut barrier function and suppressing inflammation.
The purpose of this study was to evaluate the relieving effect of tilapia head glycolipids (TH-GLs) on dextran sulfate sodium (DSS)-induced colitis in mice and to further explore its mechanism. Mice were orally administered 3% (w/v) DSS to establish a model of ulcerative colitis (UC), and subsequently treated with TH-GLs or sulfasalazine. In addition, the expression of key targets in the intestinal mucosal barrier and the inflammatory signal pathway were studied by combining immunochemical analysis techniques. The results showed that varying doses of TH-GLs can significantly improve colon lesions caused by DSS, reduce histological scores, increase mucus secretion, extend colon length, increase weight, and inhibit the occurrence of inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), Interleukin-113 (IL-113), and Interleukin- 6 (IL-6). Further, studies have shown that TH-GLs increase the secretion of MUC2 and up-regulate the expression of tight junction related proteins, such as ZO-1 and Occludin. In addition, TH-GLs significantly down-regulated the protein expression levels of TNF-alpha, IKK-13, and nuclear factor-kappa B (NF-kappa B). Here, we have elucidated the potential mechanism of TH-GLs in protecting mice with colitis. In general, this study shows that TH-GLs could improve the symptoms of UC by improving the gut barrier and inhibiting inflammatory signals, which provides a scientific basis for future clinical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available